Subgroup-specific target of nt-probnp level in heart failure with preserved ejection fraction

被引：0

作者：

Sakamoto, Daisuke ^{[1
]}

Sotomi, Y. ^{[1
]}

Nakatani, D. ^{[1
]}

Okada, K. ^{[1
]}

Seo, M. ^{[2
]}

Yano, M. ^{[3
]}

Hyashi, T. ^{[4
]}

Nakagawa, A. ^{[5
]}

Nakagawa, Y. ^{[6
]}

Tamaki, S. ^{[7
]}

Yasumura, Y. ^{[5
]}

Yamada, T. ^{[2
]}

Hikoso, S. ^{[8
]}

Sakata, Y. ^{[1
]}

机构：

[1] Osaka Univ, Grad Sch Med, Osaka, Japan

[2] Osaka Gen Med Ctr, Osaka, Japan

[3] Osaka Rosai Hosp, Cardiol, Osaka, Japan

[4] Osaka Police Hosp, Cardiol, Osaka, Japan

[5] Amagasaki Chuo Hosp, Amagasaki, Hyogo, Japan

[6] Kawanishi City Hosp, Kawanishi, Japan

[7] Rinku Gen Med Ctr, Osaka, Japan

[8] Nara Med Univ, Nara, Japan

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：53 / 54

页数：2

共 50 条

[21] Correlates of Plasma NT-proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial
Chiu, Leonard
Agrawal, Vineet
Armstrong, David
Brittain, Evan
Collins, Sheila
Hemnes, Anna R.
Hill, Joseph A.
Lindenfeld, Joann
Shah, Sanjiv J.
Stevenson, Lynne W.
Wang, Thomas J.
Gupta, Deepak K.
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (07):
[22] Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial
McKelvie, Robert S.
Komajda, Michel
McMurray, John
Zile, Michael
Ptaszynska, Agata
Donovan, Mark
Carson, Peter
Massie, Barry M.
JOURNAL OF CARDIAC FAILURE, 2010, 16 (02) : 128 - 134
[23] Associations Between Clinical Characteristics and NT-proBNP in Heart Failure with Preserved Ejection Fraction: Data from the KaRen Study
Lund, Lars H.
Donal, Erwan
Oger, Emmanuel
Hage, Camilla
Persson, Hans
Haugen-Lofman, Ida
Daubert, Jean-Claude
Linde, Cecilia
CIRCULATION, 2012, 126 (21)
[24] Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
Podzolkov, V., I
Dragomiretskaya, N. A.
Tolmacheva, A., V
Shvedov, I. I.
Ivannikov, A. A.
Yu, Akyol, V
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (04) : 310 - 319
[25] NT-proBNP for functional capacity assessment in patients with heart failure with reduced ejection fraction
Daniel Gomes, D.
Cunha, G.
Ferreira, J.
Maltes, S.
Rocha, B.
Albuquerque, F.
Paiva, M.
Santos, R.
Gama, F.
Freitas, P.
Moreno, L.
Durazzo, A.
Mendes, M.
EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 80 - 81
[26] Rising NT-probnp Levels Are Associated With Reduced Survival in Patients With Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) and Reduced Ejection Fraction (HFrEF)
Poonacha, Thejaswi
Sahni, Nishant
CIRCULATION, 2015, 132
[27] Longitudinal evaluation of ventricular ejection fraction and NT-proBNP across heart failure subgroups
Martinsson, Andreas
Oest, Petter
Wiborg, Maj-Britt
Reitan, Oyvind
Smith, J. Gustav
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2018, 52 (04) : 205 - 210
[28] NT-proBNP - a marker of coronary artery disease in patients with preserved ejection fraction
Tasheva, R.
Grigorov, M.
Vitlianova, K.
EUROPEAN HEART JOURNAL, 2016, 37 : 391 - 391
[29] Correlation Between Body Mass Index and NT-proBNP Levels in Heart Failure With Preserved Ejection Fraction: Implications for Clinical Outcomes
Vungarala, Soumya
Jani, Vivek
Vaishnav, Joban
Hahn, Virginia S.
Kass, David A.
Sharma, Kavita
CIRCULATION, 2023, 148
[30] INTERLEUKIN-1 BLOCKADE REDUCES NT-PROBNP SERUM LEVELS IN PATIENTS WITH STABLE HEART FAILURE WITH PRESERVED EJECTION FRACTION
Trankle, Cory
Canada, Justin
Carbone, Salvatore
Buckley, Leo
Del Buono, Marco Giuseppe
Christopher, Sanah
Kadariya, Dinesh
Vo, Chau
Abouzaki, Nayef
Arena, Ross
Van Tassell, Benjamin
Abbate, Antonio
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 869 - 869

← 1 2 3 4 5 →